Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.


A family of anaerobic to facultatively anaerobic, ordinarily nonmotile bacteria (order Eubacteriales) containing straight or curved, gram-positive rods that usually occur singly or in chains; motile cells are peritrichous. These organisms have complex organic nutritional requirements; they produce lactic acid from carbohydrates. They are found in fermenting animal and plant products where carbohydrates are available; they are also found in the mouth, vagina, and intestinal tract of various warm-blooded animals, including humans. Only a few species are pathogenic. The type genus is Lactobacillus, which contains 56 species.
Farlex Partner Medical Dictionary © Farlex 2012
References in periodicals archive ?
Groups 2% and 4% Zn-HA and 8% Zn-HA significantly inhibited Streptococcus mutans, Lactobacillaceae, and Streptococcus sobrinus growth (p < 0.05).
The pigs also had much smaller proportions of bacteria from the lactobacillaceae family.
Furthermore, MS patients treated with glatiramer acetate showed an increase in Bacteroidaceae, Faecalibacterium, Ruminococcus, Lactobacillaceae, Clostridium, and other members of the class Clostridiales when compared with untreated MS patients.
Several surgery index changes in taxonomy composition Antibiotic Antibiotic treatment treatment in reduced endotoxemia, Antibiotic treatment high-fat glucose intolerance, changes microbiome diet-induced body weight gain, architecture of diabetic mice inflammation, and high-fat diet-induced oxidative stress diabetic mice Fecal transplant Increase in from healthy Prevents Bacteroidetes and mice to T1DM autoimmunity, and decrease in genetically insulitis and delays Firmicutes and susceptible mice T1DM development Clostridiaceae and Lactobacillaceae abundance Antibiotic treatment of Antibiotic treatment Antibiotic treatment biobred delayed/protected lowered Bacteroides diabetes-prone against TIDM spp.
The genus Lactobacillus of the family Lactobacillaceae and the Pseudomonas of the family Pseudomonadaceae increased.
MDQ Taxonomy MJQ1 MJQ2 MJQ3 GJQ1 Bacteria 1.39 1.69 0.83 1.68 Actinobacteria* 5.51 4.69 3.76 2.56 Actinobacteria* 5.5 4.7 3.8 2.6 Pseudonocardiaceae* 2.7 2.1 1.6 1 Bacteroidetes** 0.36 0.53 0.49 0.07 Sphingobacteriia** 0.3 0.5 0.4 0.1 Firmicutes 41.63 28.69 30.46 33.51 Bacilli 41.4 28.5 30.3 33.4 Bacillaceae 13.4 5.3 9.8 18 Staphylococcaceae* 5.8 4.5 3.4 1.5 Thermoactinomycetaceae 1.6 1.4 1.3 1.5 Enterococcaceae 1.2 0.7 0.7 1 Lactobacillaceae 4.3 4.1 3.8 3.4 Leuconostocaceae 10 8.7 7.3 3 Streptococcaceae 2 1.4 1.4 1.5 Clostridia 0.2 0.2 0.2 0.1 Cyanobacteria 0.13 1.29 0.24 0.17 Chloroplast 0.1 1.3 0.2 0.2 Proteobacteria 50.86 62.95 64.07 61.91 Alphaproteobacteria 0.2 1 0.5 0.3 Betaproteobacteria 0.10.
For example, the absence of MyD88, an adaptor molecule involved in TLR signaling, protects NOD mice from autoimmune T1D by inducing a protective microbiota profile characterized by a low Firmicutes/Bacteroidetes ratio and Lactobacillaceae strain enrichment [6].
Here, we demonstrate that administration of the Lactobacillaceae-enriched VSL#3 probiotic, alone or in combination with RA, prevents T1D in NOD mice by enriching the local microbiota with Lactobacillaceae strains and by inducing substantial modifications in the microbiota composition with increase in Clostridia and Rikenellaceae species and reduction in the Bacteroidetes strain S24-7 In addition, VSL#3 administration and the resulting microbiota modifications generate a protolerogenic intestinal microenvironment with high expression of IDO and low expression of inflammatory IL-1[beta].
Although it was hypothesized that VSL#3, which is a probiotic enriched in Lactobacillaceae strains, prevented T1D by favoring colonization of the intestine of NOD mice with beneficial bacteria, comparative analysis of the microbiota profiles in VSL#3-treated and untreated NOD mice has never been performed.